Approval · Notice of Compliance 23181 · 2020
REBIF: Notice of Compliance 23181
Issued February 6, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23181
- Date
- February 6, 2020
- Company
- Emd Serono A Division Of Emd Inc CanadaMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph update
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REBIF | Not yet assigned | — |
Medicinal ingredients
- INTERFERON BETA-1A 66 MCG per 1.5ML
- INTERFERON BETA-1A 132 MCG per 1.5ML
- INTERFERON BETA-1A 22 MCG per 0.5ML
- INTERFERON BETA-1A 44 MCG per 0.5ML